Announcements Trials
Browse Landscape

Phase

Phase NA 32Phase 2 28Phase 3 10Phase 1/2 5Phase 1 5Phase 4 2Phase 2/3 2Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Plasma cell 1Other 1Lymphoid 1

Conditions

Head and Neck Neoplasms 43Thyroid Neoplasms 18Thyroid Nodule 7Squamous Cell Carcinoma of Head and Neck 7Mouth Neoplasms 7Lung Neoplasms 6Thyroid Diseases 5Neoplasm Metastasis 5Goiter 5Pain, Postoperative 4Nasopharyngeal Neoplasms 4Nasopharyngeal Carcinoma 4Carcinoma, Renal Cell 4Breast Neoplasms 4Parathyroid Neoplasms 3Pancreatic Neoplasms 3Oropharyngeal Neoplasms 3Mucositis 3Melanoma 3Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Agnosia 3Xerostomia 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Tobacco Use Disorder 2Thyroid Cancer, Papillary 2Stomatitis 2Stomach Neoplasms 2

Interventions

Benzydamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Stomatitis × Head & Neck × Clear all
NCT05055726 2022-11-16

BOOM

Aziende Chimiche Riunite Angelini Francesco S.p.A

Phase 4 Completed
100 enrolled
Head & Neck

Head and Neck Neoplasms, Stomatitis

NCT01283906 2013-09-12

MuGard

Access Pharmaceuticals, Inc.

Phase 4 Completed
120 enrolled
Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Neoplasms, Squamous Cell, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡